KR930017891A - 비페닐 치환된 퀴놀린 유도체 - Google Patents

비페닐 치환된 퀴놀린 유도체 Download PDF

Info

Publication number
KR930017891A
KR930017891A KR1019930002015A KR930002015A KR930017891A KR 930017891 A KR930017891 A KR 930017891A KR 1019930002015 A KR1019930002015 A KR 1019930002015A KR 930002015 A KR930002015 A KR 930002015A KR 930017891 A KR930017891 A KR 930017891A
Authority
KR
South Korea
Prior art keywords
oxy
pharmaceutically acceptable
biphenyl
tetrazol
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019930002015A
Other languages
English (en)
Korean (ko)
Inventor
에반 리오노 데니스
로이드 존
Original Assignee
니콜라스 피. 말라테스티닉
이이. 아르. 스퀴브 앤드 산즈, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니콜라스 피. 말라테스티닉, 이이. 아르. 스퀴브 앤드 산즈, 인크. filed Critical 니콜라스 피. 말라테스티닉
Publication of KR930017891A publication Critical patent/KR930017891A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019930002015A 1992-02-14 1993-02-13 비페닐 치환된 퀴놀린 유도체 Ceased KR930017891A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US837,782 1977-09-29
US83778292A 1992-02-14 1992-02-14

Publications (1)

Publication Number Publication Date
KR930017891A true KR930017891A (ko) 1993-09-20

Family

ID=25275409

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930002015A Ceased KR930017891A (ko) 1992-02-14 1993-02-13 비페닐 치환된 퀴놀린 유도체

Country Status (16)

Country Link
EP (1) EP0556060A1 (enExample)
JP (1) JPH05286939A (enExample)
KR (1) KR930017891A (enExample)
CN (1) CN1044243C (enExample)
AU (1) AU656454B2 (enExample)
CA (1) CA2089185A1 (enExample)
FI (1) FI930621A7 (enExample)
HU (1) HU217627B (enExample)
IL (1) IL104623A (enExample)
MX (1) MX9300742A (enExample)
NO (1) NO930520L (enExample)
NZ (1) NZ245757A (enExample)
PL (1) PL172241B1 (enExample)
RU (1) RU2122540C1 (enExample)
TW (1) TW297025B (enExample)
ZA (1) ZA93531B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767129A (en) * 1995-08-24 1998-06-16 Warner-Lambert Company Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
ES2274005T3 (es) 2001-01-26 2007-05-16 Chugai Seiyaku Kabushiki Kaisha Inhibidores de malonyl-coa decarboxilasa usados como moduladores metabolicos.
EP1353662B1 (en) 2001-01-26 2007-04-18 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
CN101596191B (zh) 2001-01-26 2011-06-15 中外制药株式会社 用作代谢调节剂的丙二酰基辅酶a脱羧酶抑制剂
ATE442141T1 (de) 2001-02-20 2009-09-15 Chugai Pharmaceutical Co Ltd Verfahren zur behandlung von stoffwechselerkrankungen mit malonyl-coa- decarboxylase-hemmern
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
RU2201753C1 (ru) * 2002-03-12 2003-04-10 Нестерук Владимир Викторович Фармацевтическая композиция, обладающая диуретическим, дегидратирующим и гипотензивным действием
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
CA2533763C (en) 2003-08-01 2012-11-20 Chugai Seiyaku Kabushiki Kaisha Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
ES2309563T3 (es) 2003-08-01 2008-12-16 Chugai Seiyaku Kabushiki Kaisha Compuestos de piperidina utiles como inhibidores de malonil coenzima a descarboxilasa.
ES2353306T3 (es) 2003-08-01 2011-03-01 Chugai Seiyaku Kabushiki Kaisha Compuestos heterocíclicos útiles como inhibidores de la malonil-coa-descarboxilasa.
DE602004016530D1 (de) 2003-08-01 2008-10-23 Chugai Pharmaceutical Co Ltd Azol-verbindungen auf cyanoguanidin-basis als malonyl-coa decarboxylase-hemmer
TWI374883B (en) * 2004-08-16 2012-10-21 Theravance Inc Crystalline form of a biphenyl compound
WO2007036743A2 (en) * 2005-09-30 2007-04-05 Argenta Discovery Limited Quinolines and their therapeutic use
GB0519969D0 (en) * 2005-09-30 2005-11-09 Argenta Discovery Ltd Quinoline compounds
DK2139881T3 (da) * 2007-04-04 2012-01-30 Pulmagen Therapeutics Asthma Ltd Quinoliner og deres terapeutiske anvendelse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IE903911A1 (en) * 1989-11-20 1991-05-22 Ici Plc Diazine derivatives
US5049565A (en) * 1990-12-07 1991-09-17 Merck & Co., Inc. Microbial transformation process for preparing anti-hypertensive products
GB9102727D0 (en) * 1991-02-08 1991-03-27 Ici Plc Pharmaceutical agent
US5157040A (en) * 1991-04-05 1992-10-20 Merck & Co., Inc. Substituted quinolines as angiotensin ii antagonists

Also Published As

Publication number Publication date
CA2089185A1 (en) 1993-08-15
FI930621A0 (fi) 1993-02-12
NO930520L (no) 1993-08-16
CN1044243C (zh) 1999-07-21
NO930520D0 (no) 1993-02-12
PL172241B1 (pl) 1997-08-29
AU656454B2 (en) 1995-02-02
HU217627B (hu) 2000-03-28
FI930621A7 (fi) 1993-08-15
MX9300742A (es) 1993-09-01
IL104623A0 (en) 1993-06-10
ZA93531B (en) 1993-08-26
EP0556060A1 (en) 1993-08-18
HU9300386D0 (en) 1993-04-28
IL104623A (en) 1996-12-05
CN1075720A (zh) 1993-09-01
TW297025B (enExample) 1997-02-01
PL297713A1 (en) 1993-08-23
JPH05286939A (ja) 1993-11-02
AU3299193A (en) 1993-08-19
RU2122540C1 (ru) 1998-11-27
HUT69694A (en) 1995-09-28
NZ245757A (en) 1995-09-26

Similar Documents

Publication Publication Date Title
KR930017891A (ko) 비페닐 치환된 퀴놀린 유도체
EP1041068B1 (en) Compounds for treating and preventing diabetic complications
US4703038A (en) Combination of dihydropyridines with angiotensin converting enzymes-inhibitors
CN1794987B (zh) 具有提高的抗炎、抗血栓形成和抗血小板活性的作为降胆固醇药的氟伐他汀、普伐他汀、西立伐他汀、阿托伐他汀和罗苏伐他汀的硝基氧基衍生物
KR940005566A (ko) 퀴놀린 화합물
BR0316586A (pt) Derivados de diidropirano indol-3, 4-dione e derivados de 3-ácido oxoacético 2-hidroximetilindol substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
KR0139626B1 (ko) 강심제
RU2009141522A (ru) Дифенилдигидроимидазопиридиноны
CA2475619A1 (en) Piperidine derivatives
RU97108980A (ru) Производные бензимидазола, антигистаминовая фармацевтическая композиция и способ лечения аллергических заболеваний
KR900701759A (ko) 비-펩타이드 레닌 억제제
CA2734780C (en) Short acting benzothiazepine calcium channel blockers and uses thereof
IL155965A0 (en) Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
RU2005137155A (ru) Производные 9-азабицикло [3.3.1] нон-6-ена с гетероатомом на позиции 3 как ингибиторы ренина
WO2012019076A1 (en) Compositions and methods for preventing and treating cardiac ischemia/reperfusion injury
KR930700468A (ko) 신규의 약학적 활성을 지닌 카테콜 유도체
KR900018074A (ko) N-헤테로아릴-4-퀴놀린아민, 이의 제조방법 및 약제로서의 이의 용도
CA2486712A1 (en) Method of treating diabetes
RU2005137571A (ru) Новые производные диазабициклононена
PT1487424E (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-il-amino)fenil]-benzamida para o tratamento doenças mediadas por ang ii
RU2008148600A (ru) Производные бензиламина в качестве ингибиторов сетр
RU2001119461A (ru) Гидроксаматы сульфонамидов
PE20020910A1 (es) p-TIENILBENCIL-AMIDAS COMO AGONISTAS DE RECEPTORES DE ANGIOTENSINA-(1-7), PROCEDIMIENTO PARA SU PREPARACION Y PREPARADOS FARMACEUTICOS QUE LOS CONTIENEN
RU2008122712A (ru) Комбинация органических соединений
RU2005137184A (ru) Новые производные тропана

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930213

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980212

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930213

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19991220

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20000403

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19991220

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I